Expert Meeting

Developing Novel Endpoints Generated by Mobile Technology for Use in Clinical Trials

CTTI Project: Novel Endpoints

Meeting Location

DoubleTree Silver Spring Hotel by Hilton, 8727 Colesville Rd, Silver Spring, Maryland

 

CLICK HERE for the meeting summary.
CLICK HERE for the meeting agenda.
CLICK HERE for a list of meeting attendees.

 

Meeting Objectives

Identify how to develop novel endpoints for use in clinical trials by writing the following use cases:

  • Parkinson’s Disease: Physical activity level and gait, measured using an accelerometer, as an endpoint for Parkinson's disease
  • Heart Failure: Physical activity level, measured using an accelerometer, as an endpoint for heart failure
  • Diabetes: Blood sugar level, measured using a wearable continuous glucose monitor, as an endpoint for diabetes
  • Muscular Dystrophy: Physical activity level, measured using

 

Meeting Presentations*

  1. Mobile in Clinical Trials: Developing Novel Endpoints for use in Clinical Trials by Jennifer Goldsack
  2. Clinical Trial Endpoints from Mobile Technology: Regulatory Considerations by Elektra J. Papadopoulos
  3. Assessing and Supporting Outcome AssessmentsCategories, Context, and Evidence: Mobile Technology Novel Endpoints Workshop by Marc K. Walton
  4. Performance Outcome Assessments: Identifying Endpoints that are Meaningful and Measurable by Stephen Joel Coons
  5. Developing Performance Outcome Measures for Use with Regulatory Agencies: The Aging In Motion (AIM) Coalition Experience by Cynthia A. Bens
  6. Developing Novel Endpoints Generated by Mobile Technology for Use in Clinical Trials: The Use Case Approach by Jennifer Goldsack

*The views and opinions expressed in this presentation are those of the individual presenter and should not be attributed to the Clinical Trials Transformation Initiative, or any organization with which the presenter is employed or affiliated.